Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Return on Equity: 2011-2025

Historic Return on Equity for Northwest Biotherapeutics (NWBO) over the last 14 years, with Sep 2025 value amounting to 0.70%.

  • Northwest Biotherapeutics' Return on Equity fell 19.00% to 0.70% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.70%, marking a year-over-year decrease of 19.00%. This contributed to the annual value of 0.93% for FY2024, which is 30.00% up from last year.
  • Per Northwest Biotherapeutics' latest filing, its Return on Equity stood at 0.70% for Q3 2025, which was down 4.31% from 0.73% recorded in Q2 2025.
  • Northwest Biotherapeutics' Return on Equity's 5-year high stood at 1.12% during Q2 2023, with a 5-year trough of 0.09% in Q4 2023.
  • Its 3-year average for Return on Equity is 0.72%, with a median of 0.79% in 2023.
  • In the last 5 years, Northwest Biotherapeutics' Return on Equity slumped by 56bps in 2023 and then spiked by 80bps in 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Return on Equity (Quarterly) stood at 0.27% in 2021, then surged by 35bps to 0.62% in 2022, then crashed by 53bps to 0.09% in 2023, then spiked by 76bps to 0.85% in 2024, then decreased by 19bps to 0.70% in 2025.
  • Its last three reported values are 0.70% in Q3 2025, 0.73% for Q2 2025, and 0.78% during Q1 2025.